125 related articles for article (PubMed ID: 1564914)
1. Total blood cholesterol and contributory risk factors in an adolescent population.
Berg CL; Swanson DJ; Juhl N
J Sch Health; 1992 Feb; 62(2):64-6. PubMed ID: 1564914
[TBL] [Abstract][Full Text] [Related]
2. Adverse influences of alcohol, tobacco, and oral contraceptive use on cardiovascular risk factors during transition to adulthood.
Croft JB; Freedman DS; Cresanta JL; Srinivasan SR; Burke GL; Hunter SM; Webber LS; Smoak CG; Berenson GS
Am J Epidemiol; 1987 Aug; 126(2):202-13. PubMed ID: 3605049
[TBL] [Abstract][Full Text] [Related]
3. The interactions of body weight, age, cigarette smoking and hormone usage with blood pressure and plasma lipids in an Australian community.
Simons LA; Simons J; Jones AS
Aust N Z J Med; 1984 Jun; 14(3):215-21. PubMed ID: 6594111
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk factors in schoolchildren.
Michel U; Riechers B
J Am Coll Nutr; 1992 Jun; 11 Suppl():36S-40S. PubMed ID: 1619198
[TBL] [Abstract][Full Text] [Related]
5. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
6. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy.
Lussier-Cacan S; Xhignesse M; Desmarais JL; Davignon J; Kafrissen ME; Chapdelaine A
Metabolism; 1991 Aug; 40(8):849-54. PubMed ID: 1907348
[TBL] [Abstract][Full Text] [Related]
7. An epidemiological study of the haemostatic and other effects of oral contraceptives.
Meade TW; Brozović M; Chakrabarth R; Howarth DJ; North WR; Stirling Y
Br J Haematol; 1976 Nov; 34(3):353-64. PubMed ID: 990177
[TBL] [Abstract][Full Text] [Related]
8. Correlates of mortality in Russian and US women. The Lipid Research Clinics Program.
Davis CE; Deev AD; Shestov DB; Perova NV; Plavinskaya SI; Abolafia JM; Kim H; Tyroler HA
Am J Epidemiol; 1994 Feb; 139(4):369-79. PubMed ID: 8109571
[TBL] [Abstract][Full Text] [Related]
9. The interaction of cigarette smoking, oral contraceptive use, and cardiovascular risk factor variables in children: the Bogalusa Heart Study.
Webber LS; Hunter SM; Baugh JG; Srinivasan SR; Sklov MC; Berenson GS
Am J Public Health; 1982 Mar; 72(3):266-74. PubMed ID: 7058967
[TBL] [Abstract][Full Text] [Related]
10. Gender and ethnic differences in adolescents' attitudes toward condom use.
Hodges BC; Leavy M; Swift R; Gold RS
J Sch Health; 1992 Mar; 62(3):103-6. PubMed ID: 1619900
[TBL] [Abstract][Full Text] [Related]
11. Relationship between levels of blood lipids, vitamins C, A, and E, serum copper compounds, and urinary excretions of tryptophan metabolites in women taking oral contraceptive therapy.
Horwitt MK; Harvey CC; Dahm CH
Am J Clin Nutr; 1975 Apr; 28(4):403-12. PubMed ID: 1119436
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
[TBL] [Abstract][Full Text] [Related]
13. The effect of low-dose oral contraceptives on lipids and lipoproteins in two at-risk populations: young female smokers and older premenopausal women.
Notelovitz M; Levenson I; McKenzie L; Khan FY
Contraception; 1991 Nov; 44(5):505-16. PubMed ID: 1797465
[TBL] [Abstract][Full Text] [Related]
14. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
[TBL] [Abstract][Full Text] [Related]
15. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.
Schwingl PJ; Ory HW; Visness CM
Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):241-9. PubMed ID: 9914611
[TBL] [Abstract][Full Text] [Related]
16. Factors related to choosing oral contraception at age 15.
Kosunen E; Laippala P
Health Educ Res; 1996 Dec; 11(4):443-51. PubMed ID: 10163954
[TBL] [Abstract][Full Text] [Related]
17. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
18. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptive use and coronary risk factors in women.
Leaf DA; Bland D; Schaad D; Neighbor WE; Scott CS
Am J Med Sci; 1991 Jun; 301(6):365-8. PubMed ID: 2039021
[TBL] [Abstract][Full Text] [Related]
20. The effect of low-dose oral contraceptives on cardiorespiratory function, coagulation, and lipids in exercising young women: a preliminary report.
Notelovitz M; Zauner C; McKenzie L; Suggs Y; Fields C; Kitchens C
Am J Obstet Gynecol; 1987 Mar; 156(3):591-8. PubMed ID: 3826206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
